Annual Debt To Equity
-28.15
-32.29-779.95%
31 December 2023
Summary:
Xeris Biopharma Holdings annual debt to equity ratio is currently -28.15, with the most recent change of -32.29 (-779.95%) on 31 December 2023. During the last 3 years, it has fallen by -30.73 (-1191.09%). XERS annual debt to equity is now -779.95% below its all-time high of 4.14, reached on 31 December 2022.XERS Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Debt To Equity
-8.17
+3.78+31.63%
30 September 2024
Summary:
Xeris Biopharma Holdings quarterly debt to equity ratio is currently -8.17, with the most recent change of +3.78 (+31.63%) on 30 September 2024. Over the past year, it has dropped by -57.44 (-116.58%). XERS quarterly debt to equity is now -116.58% below its all-time high of 49.27, reached on 30 September 2023.XERS Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XERS Debt To Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -780.0% | -116.6% |
| 3 y3 years | -1191.1% | +77.1% |
| 5 y5 years | -6802.4% | -714.3% |
XERS Debt To Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -780.0% | at low | -116.6% | +77.1% |
| 5 y | 5 years | -780.0% | at low | -116.6% | +77.1% |
| alltime | all time | -780.0% | at low | -116.6% | +77.1% |
Xeris Biopharma Holdings Debt To Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -8.17(-31.6%) |
| June 2024 | - | -11.95(-52.2%) |
| Mar 2024 | - | -25.02(-11.1%) |
| Dec 2023 | -28.15(-780.0%) | -28.15(-157.1%) |
| Sept 2023 | - | 49.27(+257.0%) |
| June 2023 | - | 13.80(+121.2%) |
| Mar 2023 | - | 6.24(+50.7%) |
| Dec 2022 | 4.14(+350.0%) | 4.14(+64.3%) |
| Sept 2022 | - | 2.52(+34.8%) |
| June 2022 | - | 1.87(+30.8%) |
| Mar 2022 | - | 1.43(+55.4%) |
| Dec 2021 | 0.92 | 0.92(-102.6%) |
| Sept 2021 | - | -35.64(-910.0%) |
| June 2021 | - | 4.40(+123.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | 1.97(-23.6%) |
| Dec 2020 | 2.58(-36.1%) | 2.58(-69.0%) |
| Sept 2020 | - | 8.33(+85.5%) |
| June 2020 | - | 4.49(+107.9%) |
| Mar 2020 | - | 2.16(-46.5%) |
| Dec 2019 | 4.04(+861.9%) | 4.04(+203.8%) |
| Sept 2019 | - | 1.33(+209.3%) |
| June 2019 | - | 0.43(+43.3%) |
| Mar 2019 | - | 0.30(-28.6%) |
| Dec 2018 | 0.42(>+9900.0%) | 0.42(+27.3%) |
| Sept 2018 | - | 0.33(+94.1%) |
| June 2018 | - | 0.17(-69.1%) |
| Mar 2018 | - | 0.55(>+9900.0%) |
| Dec 2017 | 0.00(0.0%) | 0.00 |
| Dec 2016 | 0.00 | - |
FAQ
- What is Xeris Biopharma Holdings annual debt to equity ratio?
- What is the all time high annual debt to equity for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings annual debt to equity year-on-year change?
- What is Xeris Biopharma Holdings quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings quarterly debt to equity year-on-year change?
What is Xeris Biopharma Holdings annual debt to equity ratio?
The current annual debt to equity of XERS is -28.15
What is the all time high annual debt to equity for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high annual debt to equity ratio is 4.14
What is Xeris Biopharma Holdings annual debt to equity year-on-year change?
Over the past year, XERS annual debt to equity ratio has changed by -32.29 (-779.95%)
What is Xeris Biopharma Holdings quarterly debt to equity ratio?
The current quarterly debt to equity of XERS is -8.17
What is the all time high quarterly debt to equity for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high quarterly debt to equity ratio is 49.27
What is Xeris Biopharma Holdings quarterly debt to equity year-on-year change?
Over the past year, XERS quarterly debt to equity ratio has changed by -57.44 (-116.58%)